NDA provides clients with a unique insight into EU regulatory thinking and the best possible expert guidance and support to optimise the time to the European market.

NDA's mission is to ensure that patients get access to good medicines without unnecessary delay. NDA has successfully delivered on this promise for over ten years. In 2009 NDA was involved in more than 30% of all positive opinions under the EU Centralised Procedure!

The experience and knowledge of NDA's regulatory consultants are unmatched in Europe.